O le te'i anaphylactic o le fa'ama'i masani masani lea i Europa ma Amerika i Matu. Fai mai le Allergy UK, e tusa ma le 20% o tagata gasegase e tauivi ma anaphylactic reaction i Europa. O le te'i anaphylactic e mana'omia ai masini e tui ai le adrenaline e togafitia. Adrenaline auto injectors o loʻo faʻatau atu i lalo o ituaiga eseese, e pei o Emerade, Epipen ma Jext i Peretania. Le lalolagi maketi injectors taavale sa tau i le US$ US$ 1,700 Mn, i le tulaga tau, i le 2016, e tusa ai ma suʻesuʻega lata mai a Future Market Insights (FMI). Ole lipoti ile auto injectors o loʻo faʻaalia atili ai le faʻatupulaia o le faʻatupulaia ma le fua faatatau o le tuputupu aʻe o lea tausaga ma lea tausaga e 15.1% e oʻo atu i le 2026.
Auto injectors ose auala lelei o le fa'atonuga mo vaila'au fa'ama'i. O uiga faauo a le tagata faaaoga o le auto injectors e faaitiitia ai le avega o le tauaveina o nila masani ma tui. Ae ui i lea, o le faʻatapulaʻaina o faʻamatalaga e uiga i le faʻaogaina tatau o mea faʻapipiʻi taʻavale ma le maualuga o tau o oloa faʻailoga o nisi ia o mea taua e taofia ai le faʻaaogaina o masini tui i totonu o faʻalavelave faʻafuaseʻi. E faavae i luga o suʻesuʻega na faia e le McGill University's Health Center Research Institute, o tagata mamaʻi e maua mai le EpiPen mo faʻalavelave faʻafuaseʻi e le o faʻaaogaina le oloa i le vave e tatau ai.
Mo nisi fa'amatalaga i le maketi, talosagaina se fa'ata'ita'iga o lenei mea lipoti@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642
E le gata i lea, o le tele o tagata gasegase e asiasi atu i le matagaluega o faʻalavelave faʻafuaseʻi ona o le ogaoga o anaphylaxis reaction ua uma ona tuʻuina atu epinephrine, fai mai le Journal of Allergy and Clinical Immunology. O le le fa'aogaina o masini tui i le taimi sa'o e mafua ona o le leai o se malamalama e uiga i fa'ailoga o le anaphylaxis. O le le lava o le malamalama e uiga i le faʻamaʻi ma oloa e faʻatupu ai ni luʻitau taua, i le tulaga o le faʻaaogaina o oloa, mo le au gaosi oloa. E ese mai le tau maualuga, fa'atapula'aina le ola o le auto-injector peni & i lalo o le tu'uina atu o oloa (Ex. EpiPen) o lu'itau tetele ia e fa'alavelaveina ai le mana'o o le tagata ma'i mo fa'alavelave fa'afuase'i.
O le faʻateleina o faʻafouga i meafaitino ma masini galuega a le auto-injectors o loʻo faʻateleina le faʻalauteleina o le maketi o le auto injectors. I le masina o Setema 2015, na lipotia ai e le Bayer HealthCare le faʻalauiloaina o le Betaconnect - o se tui faʻaeletoroni faʻaeletoroni mo le togafitiga o le toe faʻafoʻi-faʻasalalau tele sclerosis (RRMS). Ole tui ole ta'avale e ofoina atu vaila'au atoatoa mo le fa'aleleia atili o le tausisia ma e ono fa'aitiitia ai le tau atoa. O le SHL Group e ofoina atu le tele o injectors taʻavale e mafai ona faʻaogaina suiga i tui, e pei o voluma tetele, maualuga viscosity ma isi. O loʻo taulaʻi atu le au faʻapipiʻi auto-injector i le faʻaleleia atili o galuega a le auto-injectors e faʻaleleia ai le puleaina o faʻamaʻi ma togafitiga.
Mo faʻamatalaga i le auala suʻesuʻe o loʻo faʻaaogaina i le Lipoti, Talosaga TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1642
O le malosi o le tauvaga i totonu o le maketi o injectors taʻavale ona o le puipuiga o le maʻi ua fausia ai se siosiomaga maketi oligopolistic. O le iʻuga, o faʻailoga, e pei ole EpiPen auto-injector, BD Physioject disposable auto injector, ma isi, o loʻo tumau pea o latou tulaga i le maketi. Ae ui i lea, o le mutaaga o gasegase talu ai nei ma le faʻateleina o le mamafa mai faʻalapotopotoga a le malo o le a taʻitaʻia ai le faʻaititia o tau o le injectors taʻavale ma faʻapea, faʻaitiitia ai tupe maua mo tagata gaosi oloa. E fa'amoemoe e maua ai avanoa fa'atupulaia maualuga mo le aufaipisinisi ona o le fa'atupulaia o le lagolago mai kamupani inisiua tumaoti. O lo'o fa'amauina e kamupani o lo'o tu'uina atu auaunaga tau inisiua i totonu o tui ta'avale e taugata tele ma fa'aaofia ai le fa'ato'a fa'aulufaleina o generics e afa tau. Ole aofa'iga o tupe maua mai tui fa'atumu muamua e fa'amoemoe e fa'atupula'ia i le vaitaimi o fa'ata'ita'iga ona o le si'itia o le mana'oga mo le fa'aolaina o vaila'au fa'atatau. E tatau i tagata fou o lo'o ulufale mai ona su'esu'e mae'ae'a le maketi o le Auto Injectors ina ia fa'aulu ma fa'atumauina i le maketi ma'ale'ale tau. O le suʻesuʻeina o le faʻaaliga maketi o le a maua ai faʻamatalaga e uiga i avanoa pisinisi
Ua vaevaeina e le FMI le maketi injector i le lalolagi atoa e ala i ituaiga oloa, faʻailoga, alalaupapa tufatufa & itulagi. I le tulaga o tupe maua, o le a faʻatumuina muamua mea faʻapipiʻi taʻavale o le a umia le tele o sea maketi i le vaitau o faʻataʻitaʻiga. I se isi itu, o le Fillable auto-injectors vaega o le a faʻaalia avanoa faʻatapulaʻa faʻafaigaluega, i tulaga o tupe maua, e oʻo atu i le 2026.
O lenei lipoti a le FMI o loʻo aofia ai nisi o kamupani autu o loʻo faʻagaoioia i le maketi injectors, e pei o Sanofi, Pfizer, Inc., Becton, Dickinson ma le Kamupani, Mylan NV, Novartis AG, Janssen Global Services, LLC, Antares Pharma, Amgen Inc. Bayer AG, & Eli Lilly ma Kamupani.
Faafesootai matou
Numera Iuni: 1602-006
Jumeirah Bay 2
Numera ole fanua: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| lautusi faaletagata
OA MEA E AVEA MAI LENEI TUSI:
- However, limited awareness regarding proper use of auto injectors and high price of branded products are some of the important factors curbing the adoption of auto injector devices in emergency applications.
- The global auto injectors market was valued at US$ US$ 1,700 Mn, in terms of value, in 2016, according to the latest research by Future Market Insights (FMI).
- Increasing innovations in materials and device functions of auto-injectors are driving the expansion of the auto injector market.
